News

Breast Cancer Surgery in Frail Elderly Women Linked to Poor Results

In a study appearing Aug. 29, 2018, in JAMA Surgery, UCSF researchers found that 58 percent of women who resided in a nursing home for more than 90 days before breast cancer surgery experienced significant functional decline one year after surgery. The study found that women with functional

Chronic Inflammation Can Trigger Cancers Via Newly Discovered Mechanism

​ It is well known that extended exposure to the sun’s UV rays can cause DNA mutations that lead to skin cancer. Now new research reveals that inflammation from chronic skin injury can trigger cancer-causing mutations as well by a totally distinct mechanism. The researchers – led by scientists at UC

Risk of Heart Attacks is Double for Daily E-Cigarette Users

Use of e-cigarettes every day can nearly double the odds of a heart attack, according to a new analysis of a survey of nearly 70,000 people, led by researchers at UC San Francisco. The research also found that dual use of e-cigarettes and conventional cigarettes – the most common use pattern among e

SFCAN Researchers Hear Students' Ideas on Cancer Prevention Messaging

On Friday August 3, a group of local students presented their ideas on cancer screening and prevention marketing campaigns to experienced cancer researchers as part of the Science Education Partnership's San Francisco Health Investigators (SFHI) program. UCSF Faculty and staff were on hand

UCSF Medical Center Is Best Hospital in California for 2018-19

UCSF Medical Center has been recognized again as the top hospital in California and among the finest hospitals nationwide in U.S. News & World Report’s 2018-2019 Best Hospitals survey. In this year’s results, released Aug. 14, UCSF ranked sixth on the national Best Hospitals Honor Roll and received

Blakely and Smith Named 2018 Damon Runyon Clinical Investigators

Collin Blakely, MD, PhD, and Catherine Smith, MD, were named 2018 Damon Runyon Clinical Investigators by the Damon Runyon Cancer Research Foundation. Blakely and Smith were among just six investigators nationally to receive this award supporting young physician-scientists working to improve the

'Undruggable' Cancers Slowed by Targeting Growth Signals

As many as 50 percent of human cancer cases — across a wide variety of tissues — involve defects in a common cellular growth signaling pathway. These defects have so far defied most attempts to develop targeted therapies, leading some in the field to conclude that they may be “undruggable.” Now